Corient Private Wealth LP Invests $1.82 Million in Arcus Biosciences, Inc. $RCUS
MarketBeat
Corient Private Wealth LP bought a new position in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm bought 59,134 shares of the company's stock, valued at approximately $1,823,000. Several other hedge funds have
NYSE:RCUS